65 filings
8-K
BIOR
Biora Therapeutics Inc
2 Apr 24
Entry into a Material Definitive Agreement
4:48pm
8-K
BIOR
Biora Therapeutics Inc
26 Mar 24
Biora Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
4:10pm
8-K
BIOR
Biora Therapeutics Inc
11 Mar 24
Entry into a Material Definitive Agreement
8:11am
8-K
BIOR
Biora Therapeutics Inc
16 Jan 24
Biora Therapeutics Provides Outlook for 2024
5:20pm
8-K
BIOR
Biora Therapeutics Inc
18 Dec 23
Transaction results in nearly 60% reduction in net debt and brings $16.7 million in new capital for the company
8:06am
8-K
mrgxxbmz6 3y
15 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:25pm
8-K
tr2nhm m6h
1 Dec 23
Biora Therapeutics Announces FDA Clearance of IND Application for Drug/Device Combination
6:06am
8-K
27iiyxbr4k
13 Nov 23
Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results
4:10pm
8-K
77hreuix6519i1
13 Oct 23
Unregistered Sales of Equity Securities
6:04am
8-K
hbgd8sh iw
11 Oct 23
Unregistered Sales of Equity Securities
6:01am
8-K
9tyb1 pa52mxo
6 Oct 23
Entry into a Material Definitive Agreement
5:19pm
8-K
4hv2dy7zpfcl sb4e
19 Sep 23
Transaction results in a debt reduction of $50 million for the company
8:06am
8-K
82la0ptm
14 Aug 23
Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results
12:00am
8-K
b1danxz
15 Jun 23
Departure of Directors or Certain Officers
4:30pm
8-K
lorqba gyl282p
14 Jun 23
Biora Therapeutics Announces Closing of $8 Million Registered Direct Offering of Common Stock and Warrants Priced At-the-market Under Nasdaq Rules
4:11pm
8-K
lmvukbn
8 Jun 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
uj6cr
15 May 23
Biora Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results
4:06pm
8-K
js1gjhog 0mt4627x
7 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:15pm
8-K
j29ctg80
30 Mar 23
Biora Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2022 Financial Results
4:06pm
8-K
l83bku1
13 Mar 23
Regulation FD Disclosure
6:08am